Comparative Effectiveness of Intranasal Dexmedetomidine–Midazolam versus Oral Chloral Hydrate Targeting Moderate Sedation during Pediatric Transthoracic Echocardiograms

Abstract

Objective To compare efficacy and safety of two moderate sedation regimens for transthoracic echocardiography (TTE): intranasal dexmedetomidine–midazolam (DM) versus oral chloral hydrate (CH) syrup.

Method This was a retrospective cohort of 93 children under 4 years of age receiving moderate sedation with either DM or CH for TTE from January 2011 through December 2014.

Measurements and Main Results Forty-nine patients received oral CH and 44 received the intranasal combination of DM. The demographics between groups were similar except the DM patients were slightly older and heavier (each p < 0.05). Failure rate between groups did not reach statistical significance (CH 14.3% vs. DM 6.8%; p = 0.324). Total sedation to discharge time was similar between groups (CH 89.4 minutes vs. DM 89.6 minute; p = 0.97). Cardiopulmonary data did reveal a significantly lower heart rate (101.9 vs. 91.7; p < 0.001) and respiratory rate (23.4 vs. 21.0, p = 0.03) in the DM group, but no difference in blood pressure measurements or echo determined shortening fraction.

Conclusion These data support the use of intranasal DM as a safe and efficacious method of moderate sedation for children undergoing TTE.

Keywords

intranasal dexmedetomidine–midazolam - chloral hydrate - transthoracic echocardiography

• References

• 1 Malviya S, Voepel-Lewis T, Tait AR, Merkel S, Tremper K, Naughton N. Depth of sedation in children undergoing computed tomography: validity and reliability of the University of Michigan Sedation Scale (UMSS). Br J Anaesth 2002; 88 (02) 241-245
• 2 Wolfe TR, Braude DA. Intranasal medication delivery for children: a brief review and update. Pediatrics 2010; 126 (03) 532-537
• 3 Miller JL, Ashford JW, Archer SM, Rudy AC, Wermeling DP. Comparison of intranasal administration of haloperidol with intravenous and intramuscular administration: a pilot pharmacokinetic study. Pharmacotherapy 2008; 28 (07) 875-882
• 4 Wermeling DP, Miller JL, Archer SM, Manaligod JM, Rudy AC. Bioavailability and pharmacokinetics of lorazepam after intranasal, intravenous, and intramuscular administration. J Clin Pharmacol 2001; 41 (11) 1225-1231
• 5 Veldhorst-Janssen NM, Fiddelers AA, van der Kuy PH, Neef C, Marcus MA. A review of the clinical pharmacokinetics of opioids, benzodiazepines, and antimigraine drugs delivered intranasally. Clin Ther 2009; 31 (12) 2954-2987
• 6 Fösel T, Hack C, Knoll R, Kraus GB, Larsen R. Nasal midazolam in children, plasma concentrations and the effect on respiration. Paediatr Anaesth 1995; 5 (06) 347-353
• 7 Yuen VM, Hui TW, Irwin MG. , et al. A randomised comparison of two intranasal dexmedetomidine doses for premedication in children. Anaesthesia 2012; 67 (11) 1210-1216
• 8 Cimen ZS, Hanci A, Sivrikaya GU, Kilinc LT, Erol MK. Comparison of buccal and nasal dexmedetomidine premedication for pediatric patients. Paediatr Anaesth 2013; 23 (02) 134-138
• 9 Gyanesh P, Haldar R, Srivastava D, Agrawal PM, Tiwari AK, Singh PK. Comparison between intranasal dexmedetomidine and intranasal ketamine as premedication for procedural sedation in children undergoing MRI: a double-blind, randomized, placebo-controlled trial. J Anesth 2014; 28 (01) 12-18
• 10 Jia JE, Chen JY, Hu X, Li WX. A randomised study of intranasal dexmedetomidine and oral ketamine for premedication in children. Anaesthesia 2013; 68 (09) 944-949
• 11 Baldwa NM, Padvi AV, Dave NM, Garasia MB. Atomised intranasal midazolam spray as premedication in pediatric patients: comparison between two doses of 0.2 and 0.3 mg/kg. J Anesth 2012; 26 (03) 346-350
• 12 Mekitarian Filho E, de Carvalho WB, Gilio AE, Robinson F, Mason KP. Aerosolized intranasal midazolam for safe and effective sedation for quality computed tomography imaging in infants and children. J Pediatr 2013; 163 (04) 1217-1219
• 13 Ambi US, Joshi C, Ganeshnavar A, Adarsh E. Intranasal dexmedetomidine for paediatric sedation for diagnostic magnetic resonance imaging studies. Indian J Anaesth 2012; 56 (06) 587-588
• 14 Greenberg B, Schoonover J, Graf A. , et al. Intranasal Combination Dexmedetomidine and Midazolam for Pediatric Procedural Sedation. Available at http://www2.pedsanesthesia.org/meetings/2010winter/syllabus/pdfs/abstracts/wapd/P134.pdf . Accessed August 29, 2016
• 15 Miller JW, Loepke A, Bernard P. Nasal dexmedetomidine sedation for pediatric transthoracic echocardiography. World J Ped and Cardiovasc Surg 2015; 6: 154-154
• 16 Kleinman ME, Chameides L, Schexnayder SM. , et al. Part 14: pediatric advanced life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122 (Suppl. 03) S876-S908
• 17 Li BL, Ni J, Huang JX, Zhang N, Song XR, Yuen VM. Intranasal dexmedetomidine for sedation in children undergoing transthoracic echocardiography study--a prospective observational study. Paediatr Anaesth 2015; 25 (09) 891-896
• 18 Reynolds J, Rogers A, Medellin E, Guzman JA, Watcha MF. A prospective, randomized, double-blind trial of intranasal dexmedetomidine and oral chloral hydrate for sedated auditory brainstem response (ABR) testing. Paediatr Anaesth 2016; 26 (03) 286-293
• 19 Miller J, Xue B, Hossain M, Zhang MZ, Loepke A, Kurth D. Comparison of dexmedetomidine and chloral hydrate sedation for transthoracic echocardiography in infants and toddlers: a randomized clinical trial. Paediatr Anaesth 2016; 26 (03) 266-272
• 20 Nafiu OO, Voepel-Lewis T, Morris M. , et al. How do pediatric anesthesiologists define intraoperative hypotension?. Paediatr Anaesth 2009; 19 (11) 1048-1053
• 21 Hill GD, Walbergh DB, Frommelt PC. Efficacy of reconstituted oral chloral hydrate from crystals for echocardiography sedation. J Am Soc Echocardiogr 2016; 29 (04) 337-340